Literature DB >> 17042003

Adherence with drug therapy in the rheumatic diseases Part two: measuring and improving adherence.

Jackie Hill1.   

Abstract

Part one of this review highlighted the problem of high rates of non-adherence with drug therapy in the rheumatic diseases. Part two addresses the problem of assessing adherence to drug therapy, focuses on factors affecting medication taking and discusses interventions that can help to improved adherence. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Year:  2005        PMID： 17042003     DOI： 10.1002/msc.4

Source DB:  PubMed          Journal:  Musculoskeletal Care        ISSN： 1478-2189


  4 in total

1.  Dalbavancin for outpatient parenteral antimicrobial therapy of skin and soft tissue infections in a returning traveller : Proposal for novel treatment indications.

Authors:  Johannes Mischlinger; Heimo Lagler; Nicole Harrison; Michael Ramharter
Journal:  Wien Klin Wochenschr       Date:  2017-08-03       Impact factor: 1.704

2.  Cultural adaptation of a compliance questionnaire for patients with rheumatoid arthritis to a Korean version.

Authors:  Ju Yeun Lee; So Young Lee; Hyeon Joo Hahn; In Ja Son; Suh Gyung Hahn; Eun Bong Lee
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 2.884

Review 3.  Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development.

Authors:  Trevor van Mierlo; Rachel Fournier; Michael Ingham
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

4.  Demographic and Indication-Specific Characteristics Have Limited Association With Social Network Engagement: Evidence From 24,954 Members of Four Health Care Support Groups.

Authors:  Trevor van Mierlo; Xinlong Li; Douglas Hyatt; Andrew T Ching
Journal:  J Med Internet Res       Date:  2017-02-17       Impact factor: 5.428
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.